Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Proposes Changes To ASP Reporting Requirements For Part B Drugs

Executive Summary

CMS is proposing to expand average sales price (ASP) data reporting requirements for manufacturers to include wholesale acquisition costs of Medicare Part B drugs

You may also be interested in...

Medicaid Would Pay ASP+6% To Pharmacies Under White House Bill

The Centers for Medicare & Medicaid Services is forging ahead with its proposal to set pharmacy reimbursement levels under Medicaid at average sales price plus 6% for drugs, despite opposition from industry groups and state governors

“Average Sales Price” Rule Issued; Definition Mirrors Medicare Rx Law

CMS' definition of "average sales price" for drugs closely follows the language in the Medicare Rx law

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts